Antibiotics Market Size

  • Report ID: 4465
  • Published Date: Oct 11, 2024
  • Report Format: PDF, PPT

Antibiotics Market Size

Antibiotics Market size was valued at USD 50.55 billion in 2024 and is expected to cross USD 142.07 billion by the end of 2037, expanding at more than 8.2% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of antibiotics is estimated at USD 53.91 billion. The growth of the market is primarily attributed to the worldwide growing prevalence of various communicable diseases, such as TB, HIV, and others. As per the World Health Organization (WHO) statistics, in 2020, an estimated 1.5 million (UI 1.0 to 2.0 million) people were infected with HIV for the first time. This brought the global HIV population to 38.4 million people by 2021.

Antibiotics are antibacterial compounds that are active against bacteria. It is the most common type of antibacterial agent used to treat bacterial infections. Antibiotic medications are commonly used to treat and prevent such infections. They either kill or inhibit bacterial growth. Such factor is leading up the growing consumption of various types of antibiotics across the globe. For instance, global antibiotic consumption rates surged by 47% between 2000 and 2018 (from 9.8 to 14.3 defined daily doses (DDD) per 1000 people per day).


Antibiotics Market
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4465
  • Published Date: Oct 11, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of antibiotics is estimated at USD 53.91 billion.

The antibiotics market size was valued at USD 50.55 billion in 2024 and is expected to cross USD 142.07 billion by the end of 2037, expanding at more than 8.2% CAGR during the forecast period i.e., between 2025-2037. Growing prevalence of respiratory diseases, surge in drug combinations over mono-therapy, escalation in urinary tract infections (UTIs) will drive the market growth.

Asia Pacific is anticipated to hold majority industry share by 2037, backed by growing prevalence of infectious diseases, increasing consumption of antibiotics by regional population, significantly growing population, and growing healthcare expenditure in the region.

The major players in the market include F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, Bristol-Myers Squibb Company, Teva Pharmaceuticals Industries Ltd., Pfizer Inc., Abbott Laboratories, Merck & Co., Inc., Lupin Limited, Melinta Therapeutics, LLC, Bayer AG.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample